FinCanna Capital (OTC: FNNZF) CEO Andriyko Herchak discusses the cannabis royalty model, and company’s focus on the marijuana market
Newsmakers
FSD Pharma Appoints Top GW Pharmaceuticals Executive, Rupert Haynes, as Chief Executive Officer
Management addition comes as FSD accelerates specialty cannabinoid pharmaceutical global expansion strategy TORONTO, Nov. 26, 2018 – FSD Pharma Inc. (“FSD Pharma” or “FSD”) (CSE: HUGE) (OTCQB: FSDDF) (FRA: 0K9) announced today the appointment of […]
CEO Interview
Emerald Health Therapeutics Inc. (TSX.V: EMH) CEO Chris Wagner on Medical Marijuana Trends
Add to my social media sitesSubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati
CEO Interview
Aphria Inc. (APH:TSX) CEO Vic Neufeld outlines growth strategy for 2018
Aphria Inc. (APH:TSX) CEO Vic Neufeld outlines growth strategy for 2018 to supply exploding cannabis market demand. Add to my social media sitesSubscribeDiggdel.icio.usFacebookRedditStumbleUponTechnorati